VitalConnect raises $33M for patient monitoring platform

SAN JOSE, Calif. – VitalConnect will use $33 million in recent funding to further commercialize its VitalConnect Platform. The platform integrates the company’s VitalPatch biosensor, a lightweight, wireless adhesive patch that continuously monitors and records eight patient vital signs, with cloud-based software. “The integration of wearable biosensors into existing and emerging health care environments will change the care paradigm,” said Dr. Nersi Nazari, chairman and CEO of VitalConnect, in a statement.